We personalize every aspect of the therapy to your unique needs, which ensures youre getting exactly what your body requires to thrive
Parkinson's Disease, x-Synuclein
This phenomenon is explained by the activation of complementary signaling pathways that mutually potentiate each other (Bowers et al., Endocrine 1998)
Who Should NOT Consider Peptides Based on current evidence, I would advise against peptide use in the following individuals: Anyone with a current or recent cancer diagnosis Anyone with a strong family history of hormone-sensitive cancers (breast, ovarian, uterine, prostate, colorectal) Anyone with genetic mutations predisposing to cancer (BRCA1/2, Lynch syndrome, etc.) Anyone with active autoimmune disease or severe inflammatory conditions Pregnant or breastfeeding women Anyone who has not established foundational health practices Competitive athletes (most peptides are banned substances) Anyone seeking a "quick fix" rather than commitment to comprehensive health optimization If Considering Peptides: A Cautious Approach For patients who have established solid foundations, have no contraindications, understand the limitations of current evidence, and wish to explore peptides as a potential adjunct, here is the approach I might considerwith significant caveats: Lower-Risk Starting Point Topical GHK-Cu: This has the most established safety profile and documented benefits for skin health
The solid form of any one of claims 38-40, having an X-ray power diffraction pattern which matches the XRPD pattern presented in FIG
Most researchers do not want to do unit conversions in their head every week
